Skip to main content
Top
Published in: Indian Journal of Gastroenterology 5/2011

01-09-2011 | Original Article

Prevalence of gastric cancer versus colorectal cancer in Asians with a positive fecal occult blood test

Authors: Lukejohn W. Day, John P. Cello, Ma Somsouk, John M. Inadomi

Published in: Indian Journal of Gastroenterology | Issue 5/2011

Login to get access

Abstract

Aim

Prior studies have reported conflicting results on the yield of esophagogastroduodenoscopy (EGD) in patients with a positive fecal occult blood test (FOBT). Our aim was to compare the yield between EGD and colonoscopy performed in a racially diverse population with a positive FOBT.

Methods

A retrospective, cross-sectional study of FOBT positive patients who underwent EGD and colonoscopy from January 1, 1999 to November 1, 2008. Endoscopic lesions deemed responsible for GI bleeding were identified.

Results

Two hundred and eighty-seven patients met entry criteria, among which, 63% were Asian and 81% were immigrants to the U.S. Forty-four patients had EGD findings deemed responsible for a positive FOBT, the most common being esophagitis (25.0%) and gastric ulceration (15.9%). Forty-two patients had colonoscopic findings likely responsible for a positive FOBT with the most frequent lesion being colonic polyps ≥9 mm in diameter (76.2%). Prevalence of lower and upper GI tract lesions responsible for positive FOBT was similar (14.6% vs. 15.3%, p = 0.2). There was no association between a patient reporting upper GI symptoms, or the presence of anemia and the detection of upper GI tract lesions on endoscopy. Gastric adenocarcinoma (n = 3) was as prevalent as colorectal adenocarcinoma (n = 4). All three patients with gastric adenocarcinomas were Asian (prevalence 1.6%).

Conclusions

In our racially diverse population evaluated for a positive FOBT, gastric adenocarcinoma was as prevalent as colorectal adenocarcinoma; however, gastric adenocarcinoma was limited to Asian patients. EGD and colonoscopy should be considered in the evaluation of patient populations similar to ours, particularly Asian immigrants.
Literature
1.
go back to reference Rockey DC, Koch J, Cello JP, Sanders LL, McQuaid K. Relative frequency of upper gastrointestinal and colonic lesions in patients with positive fecal occult-blood tests. N Engl J Med. 1998;339:153–9.PubMedCrossRef Rockey DC, Koch J, Cello JP, Sanders LL, McQuaid K. Relative frequency of upper gastrointestinal and colonic lesions in patients with positive fecal occult-blood tests. N Engl J Med. 1998;339:153–9.PubMedCrossRef
2.
go back to reference Velez JP, Schwesinger WH, Stauffer J, et al. Bidirectional endoscopy in patients with fecal occult blood. Surg Endosc. 2002;16:117–20.PubMedCrossRef Velez JP, Schwesinger WH, Stauffer J, et al. Bidirectional endoscopy in patients with fecal occult blood. Surg Endosc. 2002;16:117–20.PubMedCrossRef
3.
go back to reference Ali M, Yaqub M, Haider Z, Anees I, Bhargava S, Gian J. Yield of dual endoscopy for positive fecal occult blood test. Am J Gastroenterol. 2003;98:82–5.PubMedCrossRef Ali M, Yaqub M, Haider Z, Anees I, Bhargava S, Gian J. Yield of dual endoscopy for positive fecal occult blood test. Am J Gastroenterol. 2003;98:82–5.PubMedCrossRef
4.
go back to reference Chen YK, Gladden DR, Kestenbaum DJ, Collen MJ. Is there a role for upper gastrointestinal endoscopy in the evaluation of patients with occult blood-positive stool and negative colonoscopy? Am J Gastroenterol. 1993;88:2026–9.PubMed Chen YK, Gladden DR, Kestenbaum DJ, Collen MJ. Is there a role for upper gastrointestinal endoscopy in the evaluation of patients with occult blood-positive stool and negative colonoscopy? Am J Gastroenterol. 1993;88:2026–9.PubMed
5.
go back to reference Hisamuddin K, Mowat NA, Phull PS. Endoscopic findings in the upper gastrointestinal tract of faecal occult blood-positive, colonoscopy-negative patients. Dig Liver Dis. 2006;38:503–7.PubMedCrossRef Hisamuddin K, Mowat NA, Phull PS. Endoscopic findings in the upper gastrointestinal tract of faecal occult blood-positive, colonoscopy-negative patients. Dig Liver Dis. 2006;38:503–7.PubMedCrossRef
6.
go back to reference Rasmussen M, Kronborg O. Upper gastrointestinal cancer in a population-based screening program with fecal occult blood test for colorectal cancer. Scand J Gastroenterol. 2002;37:95–8.PubMedCrossRef Rasmussen M, Kronborg O. Upper gastrointestinal cancer in a population-based screening program with fecal occult blood test for colorectal cancer. Scand J Gastroenterol. 2002;37:95–8.PubMedCrossRef
7.
go back to reference Zappa M, Visioli CB, Ciatto S, et al. Gastric cancer after positive screening faecal occult blood testing and negative assessment. Dig Liver Dis. 2007;39:321–6.PubMedCrossRef Zappa M, Visioli CB, Ciatto S, et al. Gastric cancer after positive screening faecal occult blood testing and negative assessment. Dig Liver Dis. 2007;39:321–6.PubMedCrossRef
8.
go back to reference Bini EJ, Rajapaksa RC, Valdes MT, Weinshel EH. Is upper gastrointestinal endoscopy indicated in asymptomatic patients with a positive fecal occult blood test and negative colonoscopy? Am J Med. 1999;106:613–8.PubMedCrossRef Bini EJ, Rajapaksa RC, Valdes MT, Weinshel EH. Is upper gastrointestinal endoscopy indicated in asymptomatic patients with a positive fecal occult blood test and negative colonoscopy? Am J Med. 1999;106:613–8.PubMedCrossRef
9.
go back to reference Geller AJ, Kolts BE, Achem SR, Wears R. The high frequency of upper gastrointestinal pathology in patients with fecal occult blood and colon polyps. Am J Gastroenterol. 1993;88:1184–7.PubMed Geller AJ, Kolts BE, Achem SR, Wears R. The high frequency of upper gastrointestinal pathology in patients with fecal occult blood and colon polyps. Am J Gastroenterol. 1993;88:1184–7.PubMed
10.
go back to reference McCracken M, Olsen M, Chen Jr MS, et al. Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities. CA Cancer J Clin. 2007;57:190–205.PubMedCrossRef McCracken M, Olsen M, Chen Jr MS, et al. Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities. CA Cancer J Clin. 2007;57:190–205.PubMedCrossRef
11.
go back to reference Replogle ML, Glaser SL, Hiatt RA, Parsonnet J. Biologic sex as a risk factor for Helicobacter pylori infection in healthy young adults. Am J Epidemiol. 1995;142:856–63.PubMed Replogle ML, Glaser SL, Hiatt RA, Parsonnet J. Biologic sex as a risk factor for Helicobacter pylori infection in healthy young adults. Am J Epidemiol. 1995;142:856–63.PubMed
12.
go back to reference Everhart JE, Kruszon-Moran D, Perez-Perez GI, Tralka TS, McQuillan G. Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States. J Infect Dis. 2000;181:1359–63.PubMedCrossRef Everhart JE, Kruszon-Moran D, Perez-Perez GI, Tralka TS, McQuillan G. Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States. J Infect Dis. 2000;181:1359–63.PubMedCrossRef
13.
go back to reference Zuckerman G, Benitez J. A prospective study of bidirectional endoscopy (colonoscopy and upper endoscopy) in the evaluation of patients with occult gastrointestinal bleeding. Am J Gastroenterol. 1992;87:62–6.PubMed Zuckerman G, Benitez J. A prospective study of bidirectional endoscopy (colonoscopy and upper endoscopy) in the evaluation of patients with occult gastrointestinal bleeding. Am J Gastroenterol. 1992;87:62–6.PubMed
14.
go back to reference Urquhart J, Eisen G, Faigel DO, Mattek N, Holub J, Lieberman DA. A closer look at same-day bidirectional endoscopy. Gastrointest Endosc. 2009;69:271–7.PubMedCrossRef Urquhart J, Eisen G, Faigel DO, Mattek N, Holub J, Lieberman DA. A closer look at same-day bidirectional endoscopy. Gastrointest Endosc. 2009;69:271–7.PubMedCrossRef
15.
go back to reference Hsia PC, al-Kawas FH. Yield of upper endoscopy in the evaluation of asymptomatic patients with Hemoccult-positive stool after a negative colonoscopy. Am J Gastroenterol. 1992;87:1571–4.PubMed Hsia PC, al-Kawas FH. Yield of upper endoscopy in the evaluation of asymptomatic patients with Hemoccult-positive stool after a negative colonoscopy. Am J Gastroenterol. 1992;87:1571–4.PubMed
16.
go back to reference Stray N, Weberg R. A prospective study of same day bi-directional endoscopy in the evaluation of patients with occult gastrointestinal bleeding. Scand J Gastroenterol. 2006;41:844–50.PubMedCrossRef Stray N, Weberg R. A prospective study of same day bi-directional endoscopy in the evaluation of patients with occult gastrointestinal bleeding. Scand J Gastroenterol. 2006;41:844–50.PubMedCrossRef
17.
go back to reference Leighton JA, Goldstein J, Hirota W, et al. Obscure gastrointestinal bleeding. Gastrointest Endosc. 2003;58:650–5.PubMedCrossRef Leighton JA, Goldstein J, Hirota W, et al. Obscure gastrointestinal bleeding. Gastrointest Endosc. 2003;58:650–5.PubMedCrossRef
18.
go back to reference Raju GS, Gerson L, Das A, Lewis B. American Gastroenterological Association (AGA) Institute technical review on obscure gastrointestinal bleeding. Gastroenterology. 2007;133:1697–717.PubMedCrossRef Raju GS, Gerson L, Das A, Lewis B. American Gastroenterological Association (AGA) Institute technical review on obscure gastrointestinal bleeding. Gastroenterology. 2007;133:1697–717.PubMedCrossRef
19.
go back to reference Yang L, Parkin DM, Whelan S, et al. Statistics on cancer in China: cancer registration in 2002. Eur J Cancer Prev. 2005;14:329–35.PubMedCrossRef Yang L, Parkin DM, Whelan S, et al. Statistics on cancer in China: cancer registration in 2002. Eur J Cancer Prev. 2005;14:329–35.PubMedCrossRef
20.
go back to reference Nakama H, Kamijo N, Fattah AS, Zhang B. Immunologic detection of fecal occult blood from upper digestive tract diseases. Hepatogastroenterology. 1998;45:752–4.PubMed Nakama H, Kamijo N, Fattah AS, Zhang B. Immunologic detection of fecal occult blood from upper digestive tract diseases. Hepatogastroenterology. 1998;45:752–4.PubMed
21.
go back to reference Nakama H, Kamijo N, Fujimori K, Fattah AS, Zhang B. Diagnostic accuracy of immunochemical faecal occult blood test for gastric cancer. J Med Screen. 1996;3:113–4.PubMed Nakama H, Kamijo N, Fujimori K, Fattah AS, Zhang B. Diagnostic accuracy of immunochemical faecal occult blood test for gastric cancer. J Med Screen. 1996;3:113–4.PubMed
22.
go back to reference Zhou L, Yu H, Zheng S. The value of “occult blood bead” in detection of upper digestive tract disorders with bleeding. Zhonghua Zhong Liu Za Zhi. 1999;21:48–50.PubMed Zhou L, Yu H, Zheng S. The value of “occult blood bead” in detection of upper digestive tract disorders with bleeding. Zhonghua Zhong Liu Za Zhi. 1999;21:48–50.PubMed
23.
go back to reference Macrae FA, St John DJ, Caligiore P, Taylor LS, Legge JW. Optimal dietary conditions for hemoccult testing. Gastroenterology. 1982;82:899–903.PubMed Macrae FA, St John DJ, Caligiore P, Taylor LS, Legge JW. Optimal dietary conditions for hemoccult testing. Gastroenterology. 1982;82:899–903.PubMed
24.
go back to reference Holman JS, Shwed JA. Influence of sucralfate on the detection of occult blood in simulated gastric fluid by two screening tests. Clin Pharm. 1992;11:625–7.PubMed Holman JS, Shwed JA. Influence of sucralfate on the detection of occult blood in simulated gastric fluid by two screening tests. Clin Pharm. 1992;11:625–7.PubMed
25.
go back to reference Schentag JJ. False-positive “hemoccult” reaction with cimetidine. N Engl J Med. 1980;303:110.PubMed Schentag JJ. False-positive “hemoccult” reaction with cimetidine. N Engl J Med. 1980;303:110.PubMed
26.
go back to reference Jaffe RM, Kasten B, Young DS, MacLowry JD. False-negative stool occult blood tests caused by ingestion of ascorbic acid (vitamin C). Ann Intern Med. 1975;83:824–6.PubMed Jaffe RM, Kasten B, Young DS, MacLowry JD. False-negative stool occult blood tests caused by ingestion of ascorbic acid (vitamin C). Ann Intern Med. 1975;83:824–6.PubMed
27.
go back to reference Layne EA, Mellow MH, Lipman TO. Insensitivity of guaiac slide tests for detection of blood in gastric juice. Ann Intern Med. 1981;94:774–6.PubMed Layne EA, Mellow MH, Lipman TO. Insensitivity of guaiac slide tests for detection of blood in gastric juice. Ann Intern Med. 1981;94:774–6.PubMed
29.
go back to reference Kato I, Tominaga S, Ito Y, et al. A prospective study of atrophic gastritis and stomach cancer risk. Jpn J Cancer Res. 1992;83:1137–42.PubMedCrossRef Kato I, Tominaga S, Ito Y, et al. A prospective study of atrophic gastritis and stomach cancer risk. Jpn J Cancer Res. 1992;83:1137–42.PubMedCrossRef
30.
go back to reference Barker DJ, Coggon D, Osmond C, Wickham C. Poor housing in childhood and high rates of stomach cancer in England and Wales. Br J Cancer. 1990;61:575–8.PubMedCrossRef Barker DJ, Coggon D, Osmond C, Wickham C. Poor housing in childhood and high rates of stomach cancer in England and Wales. Br J Cancer. 1990;61:575–8.PubMedCrossRef
Metadata
Title
Prevalence of gastric cancer versus colorectal cancer in Asians with a positive fecal occult blood test
Authors
Lukejohn W. Day
John P. Cello
Ma Somsouk
John M. Inadomi
Publication date
01-09-2011
Publisher
Springer-Verlag
Published in
Indian Journal of Gastroenterology / Issue 5/2011
Print ISSN: 0254-8860
Electronic ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-011-0123-7

Other articles of this Issue 5/2011

Indian Journal of Gastroenterology 5/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine